HIGHLIGHTS
- who: Nawar Al Nasrallah from the Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Department of Medicine, Indiana University School have published the paper: Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies, in the Journal: (JOURNAL)
- what: XPC is increasingly recognized as playing an important role in the development of non-dermatologic malignancies.
- future: Future studies would benefit from studying XPC as a biomarker of cancer prognosis and response to treatment in non-dermatologic malignancies. Future studies should explore XPC targeting by small molecular inhibitors to investigate these . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.